EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type

Long Davalos iD, Brian C Callaghan iD, Lavanya Muthukumar, Simone Thomas iD, Evan L Reynolds iD, A Gordon Smith, J Robinson Singleton, Ahmet Höke iD, Senda Ajroud-Driss, Mazen M Dimachkie, Stefanie Geisler iD, David M Simpson und 2 weitere

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.70072 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Long Davalos und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Kansas University Medical Center, Kansas City, Kansas, USA. Hauptthemen laut MEDLINE: Metabolic Syndrome, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Determine the association between diabetes and metabolic syndrome (MetS) burden (number of MetS criteria fulfilled) and pain, neuropathy severity, and fiber type involvement in individuals with established polyneuropathy.

Methods

The Peripheral Neuropathy Research Registry was queried for individuals with type 1 and type 2 diabetes (DPN) and non‐diabetic peripheral neuropathy (cryptogenic sensory polyneuropathy and prediabetes) using cross‐sectional observational data. Associations between diabetes or MetS burden and pain presence (yes/no), neuropathy severity (Total Neuropathy Score reduced), and fiber type involvement (pinprick, vibration, and proprioception examination—small, large, mixed) using logistic, linear, and multinomial regression models were determined.

Results

A total of 1112 participants were included (265 DPN, 847 non‐diabetic peripheral neuropathy [NDPN]). Compared to NDPN, DPN participants were more likely to have pain, higher neuropathy severity, and mixed fiber involvement. In adjusted models, diabetes was associated with pain (odds ratio [OR] 1.85, CI: 1.15–3.03) and severity (point estimate [PE] 0.84, CI: 0.27–1.42), but not fiber type involvement. As the MetS burden increased, pain, neuropathy severity, and mixed fiber type involvement increased ( p < 0.05 for trend). In adjusted models, MetS burden was associated with pain (OR 1.23, CI: 1.06–1.41) but not severity or fiber type involvement.

Interpretation

Participants with DPN were more likely to have pain, greater neuropathy severity, and possibly more mixed fiber involvement than those with NDPN. Similarly, increasing MetS burden also led to more painful neuropathy and possibly more severe neuropathy with more mixed fiber involvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeDiabetes Mellitus, Type 2Diabetic NeuropathiesDiabetes Mellitus, Type 1NeuralgiaPolyneuropathiesHumansMaleFemaleMiddle AgedCross-Sectional StudiesAgedSeverity of Illness IndexAdultRegistries

Stichwörter der Autor:innen

cryptogenic sensory polyneuropathydiabetic neuropathyidiopathic neuropathymetabolic syndromemetabolic syndrome burden

Autor:innen und Institutionen

  • Department of Neurology, Kansas University Medical Center, Kansas City, Kansas, USA.
  • Department of Neurology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Department of Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Long Davalos, Brian C Callaghan, Simone Thomas, Evan L Reynolds, Ahmet Höke, Stefanie Geisler

Förderung

  • NIDDK NIH HHS
  • NIH NIDDK

Zitieren

APA

Davalos, L., Callaghan, B. C., Muthukumar, L., Thomas, S., Reynolds, E. L., Smith, A. G., Singleton, J. R., Höke, A., Ajroud-Driss, S., Dimachkie, M. M., Geisler, S., Simpson, D. M., PNRR Study Group, & Stino, A. M. (2025). The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70072

Vancouver

Davalos L, Callaghan BC, Muthukumar L, Thomas S, Reynolds EL, Smith AG, et al. The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70072

BibTeX
@article{Davalos2025,
  author = {Davalos, Long and Callaghan, Brian C and Muthukumar, Lavanya and Thomas, Simone and Reynolds, Evan L and Smith, A Gordon and Singleton, J Robinson and Höke, Ahmet and Ajroud-Driss, Senda and Dimachkie, Mazen M and Geisler, Stefanie and Simpson, David M and PNRR Study Group, PNRR Study Group and Stino, Amro M},
  title = {The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.70072}
}
Kostenlos starten →